Healthy Individuals Clinical Trial
Official title:
Effects of Mindfulness Practice on the Neural Circuitry of Conditioned Fear Extinction in Healthy Participants
Verified date | May 2012 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
It is well-established that the practice of mindfulness meditation leads to improvements in mental health and well-being and the cultivation of positive emotions. However, the neural mechanisms of these improvements are largely unknown. A few recent studies suggest that mindfulness meditation impacts the structure and function of the ventromedial prefrontal cortex, the hippocampus, and the amygdala. Interestingly, recent studies have shown that these regions are part of a brain circuit that is critical for the extinction of conditioned fear responses, and for the retention of fear extinction memory. Building on the overlap of these regions and on conceptual considerations, the project investigates whether mindfulness meditation could influence one's capacity to retain the memory of fear extinction. Meditation-naïve participants will be randomized to either a mindfulness-meditation based training or an active control training that controls for all mindfulness-unspecific components. Participants will undergo a fear conditioning, extinction and extinction recall protocol in an MRI scanner before and after the trainings. We hypothesize that participants who have practiced mindfulness meditation will show greater improvements in fear extinction memory after the course, and that these improvements will be correlated with anatomical and functional changes in the brain regions of interest. Improvements in fear extinction memory will also be related to improvements in self-reported psychological well-being. Merging the fields of an ancient spiritual tradition and a fundamental learning mechanism, the project investigates the underlying neural mechanisms of a practice for the enhancement of mental health and well-being.
Status | Completed |
Enrollment | 85 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 18-65 years of age Proficient in English Right-handed Free of medication that affect cerebral metabolism Able to give informed consent High stress level (defined as a score of >= 3 on the 4-item Perceived Stress Scale). Exclusion Criteria: More than 10 meditation sessions of any tradition in their lifetime, or more than 5 sessions within the last year. More than 10 yoga sessions of any tradition in their lifetime, or more than 5 sessions within the last year. History of neurologic or psychiatric disease, substance abuse or dependence that is current or within the last year. Major/chronic medical conditions History of head injury resulting in prolonged loss of consciousness and/or neurological sequelae History of seizures History of stroke Prior neurosurgical procedure Metal in the body, metal injury to the eyes Implanted pacemaker, medication pump, vagal stimulator, deep brain stimulator, TENS unit, or ventriculo-peritoneal shunt Pregnancy; breastfeeding or nursing Claustrophobia Weight > 350 lbs. |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Charlestown | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital | John Templeton Foundation, Mind and Life Institute, Hadley, Massachusetts, University of Pennsylvania |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change in MRI data | We will measure the change in functional MRI during fear conditioning, extinction, and extinction retention memory pre to post intervention. Furthermore, we will measure changes in structural MRI data, DTI data and resting state fMRI data. | pre and post intervention or wait period; first set of MRIs within 3 weeks before the course, second set of MRIs within 3 weeks after course; MRIs will take 1.5 hours each and will occur on 2 consecutive days | No |
Secondary | change in well-being | questionnaire data will also be collected pre and post the intervention / wait period; change in the scores will be assessed | pre and post intervention or waitlist period; collected when the MRIs take place; will take about one hour each | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06044896 -
Physiology of Body Lateralization on Regional Lung Ventilation Study
|
N/A | |
Completed |
NCT02101801 -
Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers
|
N/A | |
Recruiting |
NCT06101641 -
Effect of Shellac Nail Polish Application on Pulse Oximetry Measurements in Healthy Individuals
|
N/A | |
Completed |
NCT03065283 -
Effects of Diaphragm-releasing Techniques on the Lumbar Spine and Diaphragmatic Function in Healthy Women
|
N/A | |
Recruiting |
NCT01721811 -
Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism
|
N/A | |
Completed |
NCT01211717 -
The Effects of Orally Ingesting Branched Chained Amino Acids on Delayed Onset Muscle Soreness in Diabetic Patients
|
N/A | |
Completed |
NCT01568541 -
Fluoride Intake From Toothbrushig With Children's or Regular Toothpastes
|
N/A | |
Completed |
NCT04941196 -
Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition
|
Phase 1 | |
Completed |
NCT05541094 -
Study of Vitamin D Fortification of Milk and Oil
|
||
Completed |
NCT05597657 -
Normal Variation of T1 Values With Cardiac Magnetic Resonance in Healthy Individuals
|
N/A | |
Completed |
NCT03728868 -
Tolerability and Risk of Adverse Events With a Probiotic Supplement
|
N/A | |
Recruiting |
NCT04513782 -
The Contributions of Age Related Changes in the Sound Localization Pathway to Central Hearing Loss
|
||
Completed |
NCT05637060 -
Bioequivalence Study of Rosuvastatin Tablet
|
N/A | |
Not yet recruiting |
NCT05110885 -
Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices
|
||
Completed |
NCT01134978 -
Neural Mechanisms of the Contextual Interference Effect: A fNIRs and EEG Study
|
Phase 1 | |
Completed |
NCT06137534 -
Upper Extremity Pattern Exercises and Respiratory Functions
|
N/A | |
Completed |
NCT04873570 -
Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects
|
Phase 1 | |
Enrolling by invitation |
NCT01872091 -
Analysis of Neuromuscular, Circulatory and Biomechanical Responses After Cryotherapy
|
N/A | |
Completed |
NCT01872117 -
Assessment of Temperature by Infrared Thermography and Blood Conduction Velocity by Doppler After Applying Shortwave Diathermy and Microwave - Correlations With Cardiovascular and Hemodynamic Parameters
|
N/A | |
Completed |
NCT02409836 -
A Study to Assess the Ingestion of Dentifrice by Children
|
N/A |